# Dose-escalation and Food Effect Study of ZT006 in Healthy, Overweight and Obese Participants

> **NCT07307638** · PHASE1 · COMPLETED · sponsor: **Beijing QL Biopharmaceutical Co.,Ltd** · enrollment: 94 (actual)

## Conditions studied

- Overweight,Obesity

## Interventions

- **DRUG:** ZT006
- **DRUG:** ZT006
- **DRUG:** ZT006
- **DRUG:** ZT006
- **DRUG:** ZT006
- **DRUG:** ZT006
- **DRUG:** ZT006
- **DRUG:** ZT006
- **DRUG:** ZT006
- **DRUG:** Placebo of ZT006
- **DRUG:** Placebo of ZT006
- **DRUG:** Placebo of ZT006

## Key facts

- **NCT ID:** NCT07307638
- **Lead sponsor:** Beijing QL Biopharmaceutical Co.,Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-11-28
- **Primary completion:** 2025-06-14
- **Final completion:** 2025-06-24
- **Target enrollment:** 94 (ACTUAL)
- **Last updated:** 2025-12-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07307638

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07307638, "Dose-escalation and Food Effect Study of ZT006 in Healthy, Overweight and Obese Participants". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT07307638. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*